Literature DB >> 31693589

Late effects of pediatric brain tumors.

Celiane Rey-Casserly1,2, Tanya Diver1,2.   

Abstract

PURPOSE OF REVIEW: Adverse late effects of pediatric brain tumors can be numerous and complex and potentially alter the life trajectories of survivors in a multitude of ways. We review these inter-related late effects that compromise neurocognitive function, general health, social and psychological adjustment, and overall adaptive and vocational outcomes, and threaten to undermine the ability of survivors to transition independently into adulthood and effectively manage their care. Intervention/prevention strategies and advances in treatment that may reduce such late effects are discussed. RECENT
FINDINGS: Studies of neuropsychological late effects have revealed specific deficits in core cognitive functions of attention, working memory and processing speed, with many survivors demonstrating decline in working memory and processing speed over time, irrespective of tumor type or treatment. This in turn affects the ongoing development of higher order neurocognitive skills. Research also highlights the increasing burden of health-related, neuropsychological and psychosocial late effects into adulthood and impact across life outcomes.
SUMMARY: Pediatric brain tumor survivors require coordinated interdisciplinary care, ongoing evaluation and management of late effects, and timely interventions focused on mitigating the impact of late effects. The transition to adulthood can be especially vulnerable and addressing barriers to care is of paramount importance.

Entities:  

Mesh:

Year:  2019        PMID: 31693589     DOI: 10.1097/MOP.0000000000000837

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  5 in total

1.  Sleep Disturbance and Its Association With Sluggish Cognitive Tempo and Attention in Pediatric Brain Tumor Survivors.

Authors:  Ineke M Olsthoorn; Alice Ann Holland; Raymond C Hawkins; Allen E Cornelius; Muhammad Usman Baig; Grace Yang; Daniel C Holland; Wafik Zaky; Peter L Stavinoha
Journal:  Front Neurosci       Date:  2022-06-23       Impact factor: 5.152

2.  The Role of Time as a Prognostic Factor in Pediatric Brain Tumors: a Multivariate Survival Analysis.

Authors:  Eduardo Javier Barragán-Pérez; Carlos Enrique Altamirano-Vergara; Daniel Eduardo Alvarez-Amado; Juan Carlos García-Beristain; Fernando Chico-Ponce-de-León; Vicente González-Carranza; Luis Juárez-Villegas; Chiharu Murata
Journal:  Pathol Oncol Res       Date:  2020-07-13       Impact factor: 2.874

3.  Consensus Parameter: Research Methodologies to Evaluate Neurodevelopmental Effects of Pubertal Suppression in Transgender Youth.

Authors:  Diane Chen; John F Strang; Victoria D Kolbuck; Stephen M Rosenthal; Kim Wallen; Deborah P Waber; Laurence Steinberg; Cheryl L Sisk; Judith Ross; Tomas Paus; Sven C Mueller; Margaret M McCarthy; Paul E Micevych; Carol L Martin; Baudewijntje P C Kreukels; Lauren Kenworthy; Megan M Herting; Agneta Herlitz; Ira R J Hebold Haraldsen; Ronald Dahl; Eveline A Crone; Gordon J Chelune; Sarah M Burke; Sheri A Berenbaum; Adriene M Beltz; Julie Bakker; Lise Eliot; Eric Vilain; Gregory L Wallace; Eric E Nelson; Robert Garofalo
Journal:  Transgend Health       Date:  2020-12-11

4.  Predictors of Functional School Outcome in Children With Pediatric Acquired Brain Injury.

Authors:  Jan Stubberud; Ruth Hypher; Anne E Brandt; Torun G Finnanger; Eva Skovlund; Stein Andersson; Kari Risnes; Torstein B Rø
Journal:  Front Neurol       Date:  2022-04-14       Impact factor: 4.086

5.  Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial.

Authors:  Jason Fangusaro; Duane A Mitchell; Mehmet Kocak; Giles W Robinson; Patricia Ann Baxter; Eugene I Hwang; Jianping Huang; Arzu Onar-Thomas; Ira J Dunkel; Maryam Fouladi; Katherine E Warren
Journal:  Pediatr Blood Cancer       Date:  2020-10-07       Impact factor: 3.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.